USPTO issues notice of allowance for Avanir Nuedexta patent
The patent application entitled, Pharmaceutical Compositions Comprising Dextromethorphan and Quinidine for the Treatment of Neurological Disorders, claims methods for treating pseudobulbar affect or emotional lability using low-dose quinidine